These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1682225)

  • 1. [Sulfasalazine in rheumatoid arthritis].
    Segal R; Caspi D; Sukenik S; Horowitz I; Rubinov A; Fluser D; Scharf Y; Shapira D; Weinberger A; Gedz D
    Harefuah; 1991 May; 120(10):577-81. PubMed ID: 1682225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.
    Newman ED; Perruquet JL; Harrington TM
    J Rheumatol; 1991 Sep; 18(9):1379-82. PubMed ID: 1684619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfasalazine in rheumatology].
    Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
    Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
    J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sulfasalazine in the treatment of rheumatoid arthritis. A multicenter open study of 150 patients during 6 months].
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):707-13. PubMed ID: 1363986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of seronegative oligoarthritis with salazopyrine].
    Stroehmann I; Wüstenhagen E; Martini M
    Z Rheumatol; 1987; 46(2):79-82. PubMed ID: 2885989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
    O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
    J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Imundo LF; Jacobs JC
    J Rheumatol; 1996 Feb; 23(2):360-6. PubMed ID: 8882047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfasalazine or salazosulfapyridine in the treatment of rheumatoid polyarthritis. An open study of 46 patients. Review of the literature].
    Trèves R; Morvan C; Bitaudeau P; Clément S; Liozon E; Arnaud M; Archambeaud-Mouveroux F; Desproges-Gotteron R
    Rev Rhum Mal Osteoartic; 1988; 55(9):641-6. PubMed ID: 2903546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of phenytoin in rheumatoid arthritis--an open study.
    Naidu MU; Ramesh Kumar T; Anuradha RT; Rao UR
    Drugs Exp Clin Res; 1991; 17(5):271-5. PubMed ID: 1756690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm evaluation of intermittent levamisole treatment in rheumatoid arthritis.
    Veys EM; Mielants H
    J Rheumatol; 1977; 4(1):27-34. PubMed ID: 886549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic therapy of rheumatoid arthritis. Comparison of methotrexate and sulfasalazine].
    Keitel W; Keitel R; Pap T
    Z Gesamte Inn Med; 1993 Oct; 48(10):480-3. PubMed ID: 7903012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.